Bright Uro Raises $6M in Seed Financing and Grant
- Bright Uro, an Aliso Viejo, CA-Based medical device company which aims to transform care of lower urinary tract symptoms (LUTS), raised $6m in Seed funding and grant
- The USD4m round was led by Academy Investor Network, Fred Moll, and and several other angel investors
- BrightUro was also awarded a $2m Phase II SBIR grant from the National Institutes of Health (NIH)
- The company intends to use the funds to expand operations and its development efforts
- BrightUro has obtained exclusivity to the catheter-free method used with the Glean system through a licensing agreement with Cleveland Clinic
- This catheter-free design of Glean may enable physicians to gather more ambulatory data with greater physiologic accuracy than the standard of care for urodynamics
